“Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape”, Can Hematol Today, vol. 5, no. 1, pp. 24–35, Jun. 2026, doi: 10.58931/cht.2026.5185.